These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 17153911)

  • 1. Developing CT image-processing tools to accelerate progress in lung cancer drug development.
    Mulshine JL; Avila RS; Hirsch FR; Yankelevitz D
    Oncology (Williston Park); 2006 Nov; 20(12):1606, 1608-10, 1614 passim. PubMed ID: 17153911
    [No Abstract]   [Full Text] [Related]  

  • 2. Prognostic value of serial [18F]fluorodeoxyglucose PET-CT uptake in stage III patients with non-small cell lung cancer treated by concurrent chemoradiotherapy.
    Zhang HQ; Yu JM; Meng X; Yue JB; Feng R; Ma L
    Eur J Radiol; 2011 Jan; 77(1):92-6. PubMed ID: 19695804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A minimally invasive multimodality image-guided (MIMIG) system for peripheral lung cancer intervention and diagnosis.
    He T; Xue Z; Lu K; Valdivia y Alvarado M; Wong KK; Xie W; Wong ST
    Comput Med Imaging Graph; 2012 Jul; 36(5):345-55. PubMed ID: 22483054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lung cancer screening--comparison of computed tomography and X-ray.
    Fujikawa A; Takiguchi Y; Mizuno S; Uruma T; Suzuki K; Nagao K; Niijima M; Edo H; Hino M; Kuriyama T
    Lung Cancer; 2008 Aug; 61(2):195-201. PubMed ID: 18242764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imaging the early response to chemotherapy in advanced lung cancer with diffusion-weighted magnetic resonance imaging compared to fluorine-18 fluorodeoxyglucose positron emission tomography and computed tomography.
    Tsuchida T; Morikawa M; Demura Y; Umeda Y; Okazawa H; Kimura H
    J Magn Reson Imaging; 2013 Jul; 38(1):80-8. PubMed ID: 23239463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of high-resolution CT imaging data to lung cancer drug development: measuring progress: workshop IX.
    Mulshine JL; Avila R; Yankelevitz D; Baer TM; Estepar RS; Fenton L; Aldige CR
    J Thorac Oncol; 2013 Nov; 8(11):1352-5. PubMed ID: 24128711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of different contrast medium concentrations and injection protocols on quantitative and clinical assessment of FDG-PET/CT in lung cancer.
    Verburg FA; Kuhl CK; Pietsch H; Palmowski M; Mottaghy FM; Behrendt FF
    Eur J Radiol; 2013 Oct; 82(10):e617-22. PubMed ID: 23880426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamic MRI, dynamic multidetector-row computed tomography (MDCT), and coregistered 2-[fluorine-18]-fluoro-2-deoxy-D-glucose-positron emission tomography (FDG-PET)/CT: comparative study of capability for management of pulmonary nodules.
    Ohno Y; Koyama H; Takenaka D; Nogami M; Maniwa Y; Nishimura Y; Ohbayashi C; Sugimura K
    J Magn Reson Imaging; 2008 Jun; 27(6):1284-95. PubMed ID: 18504748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Symposium on diagnosis and treatment of cancer. Recent progress.
    Jpn J Med; 1988 Feb; 27(1):96-112. PubMed ID: 2452911
    [No Abstract]   [Full Text] [Related]  

  • 10. Early lung cancer detection: approaching the 'tipping point'?
    Mulshine JL
    Oncology (Williston Park); 2006 Nov; 20(12):1632. PubMed ID: 17153912
    [No Abstract]   [Full Text] [Related]  

  • 11. [Telemedicine and telecommunication vehicle].
    Cai Z; Zhang Q; Wu HX
    Zhongguo Yi Liao Qi Xie Za Zhi; 2002 Jul; 26(4):286-7. PubMed ID: 16104288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Misunderstanding image filtration in CT creates misdiagnosis risk.
    Health Devices; 2008 Sep; 37(9):284-6. PubMed ID: 19010044
    [No Abstract]   [Full Text] [Related]  

  • 13. Computer-aided detection (CAD) and assessment of malignant lesions in the liver and lung using a novel PET/CT software tool: initial results.
    Hahn S; Heusner T; Zhou X; Zhan Y; Peng Z; Hamami M; Forsting M; Bockisch A; Antoch G
    Rofo; 2010 Mar; 182(3):243-7. PubMed ID: 19859858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrated fluorine-18 fluorodeoxyglucose (18F-FDG) PET/CT compared to standard contrast-enhanced CT for characterization and staging of pulmonary tumors eligible for surgical resection.
    Quaia E; Tona G; Gelain F; Lubin E; Pizzolato R; Boscolo E; Bussoli L
    Acta Radiol; 2008 Nov; 49(9):995-1004. PubMed ID: 18651256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imatinib mesylate inhibits the growth of metastatic lung lesions in a patient with dermatofibrosarcoma protuberans.
    Mizutani K; Tamada Y; Hara K; Tsuzuki T; Saeki H; Tamaki K; Matsumoto Y
    Br J Dermatol; 2004 Jul; 151(1):235-7. PubMed ID: 15270901
    [No Abstract]   [Full Text] [Related]  

  • 16. Lung cancer screening: has there been any progress? Computed tomography and autofluorescence bronchoscopy.
    Lee P; Sutedja TG
    Curr Opin Pulm Med; 2007 Jul; 13(4):243-8. PubMed ID: 17534167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multi-slice CT spirals past single-slice CT in diagnostic efficacy.
    Kopecky KK; Buckwalter KA; Sokiranski R
    Diagn Imaging (San Franc); 1999 Apr; 21(4):36-42. PubMed ID: 10537787
    [No Abstract]   [Full Text] [Related]  

  • 18. Plasma nucleosome levels might predict response to therapy in patients with advanced non-small-cell lung cancer.
    Kumar S; Guleria R; Singh V; Bharti AC; Mohan A; Das BC
    Clin Lung Cancer; 2010 Jan; 11(1):36-44. PubMed ID: 20085866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sorafenib-induced tumor response in a patient with metastatic epithelioid angiomyolipoma.
    Lee DW; Chang H; Kim YJ; Kim KM; Lee HJ; Lee JS
    J Clin Oncol; 2014 Apr; 32(11):e42-5. PubMed ID: 24449236
    [No Abstract]   [Full Text] [Related]  

  • 20. CT and MRI of Lung Cancer.
    Laurent F; Montaudon M; Corneloup O
    Respiration; 2006; 73(2):133-42. PubMed ID: 16549940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.